Morningstar / Business Wire · Jul 2026
Announced new efficacy data for Torula Oil and named several commercial product placements, reinforcing the company’s commercialization momentum in prestige beauty.
Next-gen ingredients to decarbonize consumer products, starting w/…
Public company, workplace, funding, and market signals
C16 Biosciences is a New York-based biotechnology company that uses fungal/fermentation biomanufacturing to make Palmless™ sustainable ingredients, led by a palm-oil alternative platform that started with Torula Oil and now spans beauty, personal care, home care, and food applications.
Primary product
Palmless™ Torula Oil and the broader Palmless™ biomanufactured ingredients platform
Founded
2018
Headquarters
619 West 54th Street, 7th Floor, New York, NY 10019, United States
Team size
11-50
Work style
Onsite
Industry
Biotechnology Research
Sub-industry
Precision fermentation / industrial biotechnology ingredients
Offices
0 jobs at C16 Biosciences
Check back later for new openings
Business model
Stage
Series A / venture-backed
Total raised
$33.7M
Latest round
Venture Round · Jan 2024
Latest amount
$1M
Leadership
Co-Founder & CEO
Co-Founder & COO
Chief Scientific Officer
Head of R&D
People Ops & Experience Lead
Founders
Co-Founder
Investors
Mission-driven and collaborative; the company describes its team as 'glass-half-full change-makers' and as scientists, engineers, brand-builders, and entrepreneurs working to decarbonize consumer products.
Work style
Onsite
Compensation
No public compensation bands, salary ranges, or detailed pay signals were found on the company site or careers page.
Pricing
B2B ingredient supply and partnership-based pricing; no public list pricing found.
Differentiators
Technology
Customers
Competitors
Estimated revenue
$10M-$25M
Morningstar / Business Wire · Jul 2026
Announced new efficacy data for Torula Oil and named several commercial product placements, reinforcing the company’s commercialization momentum in prestige beauty.
The Business Journals · Jan 2025
Founder profile describing Shara Ticku’s transition from finance to climate tech and the origin story behind C16 Biosciences.
Fast Company · Mar 2024
Highlighted Palmless/Torula Oil, early sell-outs, and the company’s move from beauty into broader applications, reinforcing product-market traction.
The New York Times · Mar 2024
Profiled C16 Biosciences alongside other palm-oil-alternative startups, explaining the technology, scale challenge, and commercialization hurdles.
Business Wire · Jan 2024
Official funding announcement covering a $3.5M Gates Foundation grant and $1M Elemental investment, plus expansion into food-grade oils and fats.